# Eli Lilly and Company (LLY) — Q2-2020 Earnings Results

**Report date:** 2020-07-30 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/LLY/earnings/Q2-2020

## Post-Earnings Brief

### Headline

Eli Lilly Beats on EPS, Stock Down 5.4%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.89 | N/A | +19.62% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting their commitment to innovation. However, no specific guidance was provided for future performance.

**Key quotes:**

> We are pleased with our EPS performance this quarter.

> Our focus remains on delivering innovative treatments to patients.

### Guidance Changes

No guidance data is available for this quarter.

### What It Means

Eli Lilly's strong EPS performance indicates effective cost management and operational efficiency. However, the stock fell by 5.4% following the earnings report, likely due to the lack of revenue details and forward guidance, which may have left investors uncertain about future growth prospects.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/LLY/earnings/Q2-2020_